Lecanemab Gains FDA Approval for Early Alzheimer Disease

被引：48
|
作者：
Larkin, Howard D. D.
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2023年 / 329卷 / 05期
关键词：
D O I：
10.1001/jama.2022.24490
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：363 / 363
页数：1
相关论文
共 50 条
  • [1] Alzheimer Drug Lecanemab Gains Traditional FDA Approval
    Harris, Emily
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, : 495
  • [2] Lecanemab (Leqembi) Granted Full Approval for Early Alzheimer's Disease
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1683): : 129 - 130
  • [3] Alzheimer's disease: Lecanemab gets full FDA approval and black box safety warning
    Mahase, Elisabeth
    BMJ-BRITISH MEDICAL JOURNAL, 2023, 382 : p1580
  • [4] Lecanemab in Early Alzheimer's Disease
    van Dyck, Christopher H.
    Swanson, Chad J.
    Aisen, Paul
    Bateman, Randall J.
    Chen, Christopher
    Gee, Michelle
    Kanekiyo, Michio
    Li, David
    Reyderman, Larisa
    Cohen, Sharon
    Froelich, Lutz
    Katayama, Sadao
    Sabbagh, Marwan
    Vellas, Bruno
    Watson, David
    Dhadda, Shobha
    Irizarry, Michael
    Kramer, Lynn D.
    Iwatsubo, Takeshi
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (01): : 9 - 21
  • [5] Lecanemab in Early Alzheimer's Disease
    Zeng, Bing-Syuan H.
    Tseng, Ping-Tao
    Liang, Chih-Sung
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (17): : 1630 - 1632
  • [6] FDA green-lights lecanemab for Alzheimer’s disease
    Chemical and Engineering News, 2023, 101 (02):
  • [7] Alzheimer's Disease: Lecanemab in early Stage of the Disease?
    Simon, Annika
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (10) : 593 - 594
  • [8] Spectrascience gains FDA approval
    不详
    JOURNAL OF CLINICAL LASER MEDICINE & SURGERY, 2002, 20 (06): : 346 - 346
  • [9] Contrave gains FDA approval
    Idris, Iskandar
    DIABETES OBESITY & METABOLISM, 2011, 13 (03): : 287 - 287
  • [10] TREATMENT FOR IMPOTENCE GAINS FDA APPROVAL
    不详
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (19) : 2078 - 2079
12345